Fortis Healthcare has acquired a 34% stake in Agilus Diagnostics from private equity firms Jacob Ballas and IFC. This transaction valued Agilus at around ₹5,000 crore and increased Fortis’s holding from 57% to 91%. Agilus operates 413 laboratories and faced expansion challenges due to investors’ reluctance and rising competition from new-age online players.
| Subscribe To Our Free Newsletter |
